A Phase 1 interventional study of F2F and eSBI in Prescription Stimulant Misuse and Prescription Stimulant Diversion, sponsored by California State University, Long Beach. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-04.
Sponsored by California State University, Long Beach · Phase 1, Interventional, and Other
A pilot randomized controlled trial to assess the feasibility, acceptability, and impact of screening and brief intervention to address prescription stimulant misuse and diversion among college students.
A screening and brief intervention including a control group, face-to-face group, and e-intervention group where the focus is prevention or brief intervention or referral to treatment related to students prescription stimulant misuse and diversion behaviors. Students will complete assessments at three time points, and the health providers who implement the intervention will also complete assessments.
California State University, Long Beach is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Age 18 and student at the campus serving as the intervention site; Passive recruitment: Student has a scheduled appointment for a physical/wellness exam. Active recruitment: Student has a past 3 month history of PSM or PSD.
Exclusion Criteria:
Any eligible student who, during the course of the session, demonstrates the need for immediate mental health services, will have the study session terminated so that participant can receive needed care.
Students complete the assessments at each time point, but do not receive any intervention or informational material.
Behavioral: Control
After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
Behavioral: F2F
After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
Behavioral: eSBI
After T1 assessment, students meet with a trained provider and receive prevention or brief intervention. Students then complete assessments at two additional times.
After T1 assessment, students watch and respond to a prevention or brief intervention video series. Students then complete assessments at two additional times.
Students complete the assessments at each time point, but do not receive any intervention or informational material.
Prescription Stimulant Misuse
Students report on their experience with prescription stimulant misuse behaviors. PSM is assessed at T1, pre-intervention, and T3, 30-Days post intervention.
Time frame: 30 days
Prescription Stimulant Diversion
Students report on their experience with prescription stimulant diversion behaviors. PSD is assessed at T1, pre-intervention, and T3, 30-Days post intervention.
Time frame: 30 days
PSM Intentions
Intention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention)
Time frame: 30 days
PSD Intentions
Intention to engage in PSM is measured at T1 (pre-intervention), T2 (immediate post), and T3 (30 Day post intervention).
Time frame: 30 days
Plan to share: No — Individual data will not be shared due to confidentiality agreements with participants, but study protocol, analysis plan, informed consent, and clinical study reports will be shared.
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
California State University, Long Beach